• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anika Therapeutics Inc

+ Add to Watchlist

AKP:GR

30.850 EUR 0.100 0.32%

As of 02:06:44 ET on 08/20/2014.

Snapshot for Anika Therapeutics Inc (AKP)

Open: 30.847 Day's Range: 30.847 - 30.850 Volume: 0
Previous Close: 30.950 52wk Range: 16.685 - 38.095 1-Yr Rtn: +84.20%

Stock Chart for AKP

No chart data available.
  • AKP:GR 30.847
  • 1D
  • 1M
  • 1Y
30.950
Interactive AKP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.4348
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 2.3500
Est. PEG Ratio 0.5812
Market Cap (M EUR) 446.91
Shares Outstanding (M) 14.49
30 Day Average Volume 76
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKP

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Carol A BarnettChief Commercial OfficerJohn W Sheets JrChief Scientific Officer
More Company Profile & Key Executives for AKP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil